The liver is a 3-pound workhorse of an organ, processing much of what we take into our bodies. That includes medications, alcohol fatty foods and other toxins. But the liver has its limits. The ...

Please provide your email address to receive an email when new articles are posted on . There was an 81% increase in alcohol-associated hepatitis admissions within the first year of the COVID-19 ...

Hepatitis is a general term to describe inflammation of the liver tissue. Although it can arise from several causes, hepatitis from a viral infection is the most common. Alcoholic hepatitis is a ...

As patients come into clinic and receive appropriate follow-up, we can hopefully find ways to mitigate the increase in alcoholic hepatitis, said Nancy Reau, MD, section chief of hepatology at Rush ...

A new study published in the journal of Nature Scientific Reports showed that in individuals with severe alcohol-associated ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. In the first year of the COVID-19 pandemic, hospital admissions for alcoholic hepatitis (AH) among ...

Immunology researchers have demonstrated that alcohol promotes the proliferation of hepatitis C virus in human liver cells. By studying molecular mechanisms in cell cultures, the researchers help ...

In new research published in Liver International, researchers at Henry Ford Health System have found that people hospitalized for alcoholic hepatitis – a life threatening liver disease fueled by ...

Patients with severe alcohol-associated hepatitis (AH) need treatment for both their liver disease and their underlying alcohol use disorder (AUD), concludes a review discussing care for patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Although pre-and post-COVID-19 monthly ...

LONDON-- (BUSINESS WIRE)--Technavio has been monitoring the alcoholic hepatitis treatment market and it is poised to grow by USD 613.42 million during 2020-2024, progressing at a CAGR of 6% during the ...

Durect and investors have reached radically different conclusions about its severe alcohol-associated hepatitis phase 2 data. The biotech hailed “remarkable” results—on a secondary goal, in a ...